Skip to content

Technical issue on werkenbij.amsterdamumc.org

We are currently experiencing a technical issue with the system in which we store all applications. As a result, it is currently not possible to view your application or to submit a new one.

All completed applications submitted up to May 7, 2025, 4:00 PM have been successfully received. If you applied after that time or are unsure whether your application went through, please check whether you received a confirmation email from us. Didn't receive one? Then please try to submit your application again at a later time.

Research stories

  • Intravenous anaesthesia greatly reduces CO₂ emissions: comparable to annual emissions of Denmark
    Intravenous anaesthesia greatly reduces CO₂ emissions: comparable to annual emissions of Denmark What if you could save 98 percent of CO₂ emissions during surgery with just one change? And what if that change also improved patient recovery and saved costs? Then you's probably want to implement that adjustment as quickly as possible, preferably worldwide. That is the mission of Amsterdam UMC anaesthesiologist Niek Sperna Weiland: “Our relatively small professional group can ultimately achieve a worldwide reduction in CO₂ emissions that is as large as the annual emissions of all of Denmark.” The adjustment in question: intravenous anaesthesia, instead of an anaesthetic gas.
  • New insights into how cancer evades the immune system
    New insights into how cancer evades the immune system Research into immunotherapy against cancer typically focuses on better recognition of cancer cells by the body's own immune system. Researchers at Amsterdam UMC and Moffitt Cancer Center have taken a different approach. They investigated how cancer affects the energy management of a patient’s T cells and showed for the first time that contact with chronic lymphocytic leukaemia (CLL) cells leads to a serious energy crisis in these cells. These findings are published today in Cellular & Molecular Immunology, building on a publication earlier this month in Blood Advances.
  • Tocolytic drugs that inhibit contractions after 30 weeks of pregnancy has no effect on a baby's health
    Tocolytic drugs that inhibit contractions after 30 weeks of pregnancy has no effect on a baby's health The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health. “There was no benefit but also no harm done," says Amsterdam UMC PhD-student Larissa van der Windt. The results of the largest study concerning the effectiveness of tocolytic drugs on the health of babies, led by Amsterdam UMC, were published today in The Lancet.

Amsterdam UMC makes use of cookies

Some of these cookies are ‘strictly necessary’, or essential for technical reasons. Others are used to improve the website. We also use cookies to enable the viewing of video material and animations. By opting to “accept cookies”, you agree to the use of all of the cookies described in our cookie policy. Should you choose to “refuse cookies”, only ‘strictly necessary’ and analytics cookies will be placed on your device. You can change your preferences at any time via the cookie policy.